Clinical Trial

LDCT-SC-FI Low-dose CT Screening for Lung Cancer

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized phase II trial investigating different smoking cessation methods in study subjects undergoing lung cancer screening with low-dose CT (LDCT). The study also evaluates feasibility and outcomes of LDCT screening and potential biomarkers and AI-based evaluation on CT-scans. The study subjects fulfilling I/E-criteria are randomized in 1:1 fashion to yearly LDCT for two rounds with standard smoking cessation (control) or same LDCT approach combined to mobile application based smoking cessation (intervention).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-11-18; most recent amendment 2025-08-22.
Status change: Recruiting → Active, Not Recruiting 2023-10-02
Trial Details
NCT Number NCT05630950
Lead Sponsor Oulu University Hospital
Conditions Lung Cancer Screening
Enrollment 200 participants
Start Date 2022-11-18
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-24